BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25898720)

  • 1. Disordered binding regions of Ewing's sarcoma fusion proteins.
    Todorova R
    Bioorg Khim; 2014; 40(1):20-30. PubMed ID: 25898720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins.
    Ng KP; Potikyan G; Savene RO; Denny CT; Uversky VN; Lee KA
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):479-84. PubMed ID: 17202261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis.
    Showpnil IA; Miller KR; Taslim C; Pishas KI; Lessnick SL; Theisen ER
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.
    Kim S; Denny CT; Wisdom R
    Mol Cell Biol; 2006 Apr; 26(7):2467-78. PubMed ID: 16537893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of the EWS oncogene transcriptional activation domain.
    Ng KP; Li KK; Lee KA
    Biochemistry; 2009 Apr; 48(13):2849-57. PubMed ID: 19290668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.
    Spahn L; Siligan C; Bachmaier R; Schmid JA; Aryee DN; Kovar H
    Oncogene; 2003 Oct; 22(44):6819-29. PubMed ID: 14534527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins.
    Olsen RJ; Hinrichs SH
    Oncogene; 2001 Mar; 20(14):1756-64. PubMed ID: 11313922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.
    Cironi L; Riggi N; Provero P; Wolf N; Suvà ML; Suvà D; Kindler V; Stamenkovic I
    PLoS One; 2008 Jul; 3(7):e2634. PubMed ID: 18648544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity.
    Myatt SS; Burchill SA
    Oncogene; 2008 Feb; 27(7):985-96. PubMed ID: 17700534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
    Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
    Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of Ewing's sarcoma protein (EWS) and EWS-Fli1 in response to DNA damage.
    Klevernic IV; Morton S; Davis RJ; Cohen P
    Biochem J; 2009 Mar; 418(3):625-34. PubMed ID: 19076070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function based molecular relationships in Ewing's sarcoma.
    Todorova R
    Biomed Res Int; 2015; 2015():798426. PubMed ID: 25688366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
    Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
    Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
    Chansky HA; Hu M; Hickstein DD; Yang L
    Cancer Res; 2001 May; 61(9):3586-90. PubMed ID: 11325824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
    Lessnick SL; Braun BS; Denny CT; May WA
    Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing.
    Yang L; Chansky HA; Hickstein DD
    J Biol Chem; 2000 Dec; 275(48):37612-8. PubMed ID: 10982800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
    Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
    Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
    Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
    Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
    Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
    J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
    Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
    J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.